{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:23:21Z","timestamp":1787963001928,"version":"build-2784847793"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.clnu.2024.02.006","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T21:51:34Z","timestamp":1707515494000},"page":"900-908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Non-invasive tools for liver steatosis and steatohepatitis predict incidence of diabetes, cardiovascular disease and mortality 20 years later: The ATTICA cohort study (2002\u20132022)"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1558-194X","authenticated-orcid":false,"given":"Matina","family":"Kouvari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Chrysohoou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Damigou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios","family":"Barkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evrydiki","family":"Kravvariti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Liberopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costas","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros P.","family":"Sfikakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Pitsavos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8583-153X","authenticated-orcid":false,"given":"Demosthenes","family":"Panagiotakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2024.02.006_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A\u00a0multi-society Delphi consensus statement on new fatty liver disease nomenclature","author":"Rinella","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2024.02.006_bib2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.clnu.2024.02.006_bib3","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.2337\/dci21-0020","article-title":"Preparing for the NASH epidemic: a call to action","volume":"44","author":"Kanwal","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2024.02.006_bib4","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jhep.2018.01.023","article-title":"New insights into NAFLD and subclinical coronary atherosclerosis","volume":"68","author":"VanWagner","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2024.02.006_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2024.02.006_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12933-020-01025-4","article-title":"Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study","volume":"19","author":"Kim","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.clnu.2024.02.006_bib7","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/dom.14950","article-title":"Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long-term mortality in acute myocardial infarction","volume":"25","author":"Chin","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clnu.2024.02.006_bib8","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/jcsm.12719","article-title":"Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey","volume":"12","author":"Moon","year":"2021","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2024.02.006_bib9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/liv.13612","article-title":"Usefulness of the index of NASH \u2013 ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: an external validation study","volume":"38","author":"Younes","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.clnu.2024.02.006_bib10","doi-asserted-by":"crossref","first-page":"101145","DOI":"10.1016\/j.eclinm.2021.101145","article-title":"acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study","volume":"41","author":"Wu","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.clnu.2024.02.006_bib11","doi-asserted-by":"crossref","first-page":"155666","DOI":"10.1016\/j.metabol.2023.155666","article-title":"Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive non-alcoholic fatty liver disease indexes: results from a large multi-center study","author":"Kouvari","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.clnu.2024.02.006_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2458-3-32","article-title":"Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study","volume":"3","author":"Pitsavos","year":"2003","journal-title":"BMC Public Health"},{"key":"10.1016\/j.clnu.2024.02.006_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnu.2024.02.006_bib14","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3390\/life13051142","article-title":"Lifestyle trajectories are associated with incidence of cardiovascular disease: highlights from the ATTICA epidemiological cohort study (2002-2022)","volume":"13","author":"Damigou","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.clnu.2024.02.006_bib15","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2024.02.006_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.15403\/jgld-3404","article-title":"Fatty liver index as a simple and useful predictor for 10-year cardiovascular disease risks determined by Framingham Risk Score in the General Korean Population","volume":"30","author":"Chung","year":"2021","journal-title":"J\u00a0Gastrointest Liver Dis"},{"key":"10.1016\/j.clnu.2024.02.006_bib17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12933-022-01691-6","article-title":"The association of fatty liver index and BARD score with all-cause and cause-specific mortality in patients with type 2 diabetes mellitus: a nationwide population-based study","volume":"21","author":"Chung","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.clnu.2024.02.006_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12933-022-01483-y","article-title":"The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study","volume":"21","author":"Park","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.clnu.2024.02.006_bib19","doi-asserted-by":"crossref","first-page":"110191","DOI":"10.1016\/j.diabres.2022.110191","article-title":"The association between changes in hepatic steatosis and hepatic fibrosis with cardiovascular outcomes and mortality in patients with New-Onset type 2 Diabetes: a nationwide cohort study","volume":"194","author":"Park","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clnu.2024.02.006_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12933-021-01374-8","article-title":"The association of hepatic steatosis and fibrosis with heart failure and mortality","volume":"20","author":"Park","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.clnu.2024.02.006_bib21","doi-asserted-by":"crossref","first-page":"638615","DOI":"10.3389\/fendo.2021.638615","article-title":"The repeatedly elevated fatty liver index is associated with increased mortality: a population-based cohort study","volume":"12","author":"Lee","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.clnu.2024.02.006_bib22","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.7150\/ijms.62010","article-title":"Association of hepatic steatosis index and fatty liver index with carotid atherosclerosis in type 2 diabetes","volume":"18","author":"Wang","year":"2021","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.clnu.2024.02.006_bib23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3390\/healthcare9070899","article-title":"Prediction of cardiovascular risk using nonalcoholic fatty liver disease scoring systems","volume":"9","author":"Kweon","year":"2021","journal-title":"Healthcare"},{"key":"10.1016\/j.clnu.2024.02.006_bib24","doi-asserted-by":"crossref","first-page":"155222","DOI":"10.1016\/j.metabol.2022.155222","article-title":"Association of fatty liver index with all-cause and disease-specific mortality: a nationwide cohort study","volume":"133","author":"Chung","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.clnu.2024.02.006_bib25","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/apt.14967","article-title":"Liver fat scores predict liver disease mortality in the United States population","volume":"48","author":"Unalp-Arida","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnu.2024.02.006_bib26","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/MEG.0000000000001183","article-title":"Association of fatty liver index with the risk of incident cardiovascular disease and acute myocardial infarction","volume":"30","author":"Olubamwo","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2024.02.006_bib27","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s10620-021-06954-y","article-title":"Fatty liver index and development of cardiovascular disease: findings from the UK Biobank","volume":"66","author":"Zou","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnu.2024.02.006_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cca.2017.01.008","article-title":"Associations of the fatty liver and hepatic steatosis indices with risk of cardiovascular disease: interrelationship with age","volume":"466","author":"Kunutsor","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clnu.2024.02.006_bib29","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/dom.14923","article-title":"Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: analyses from VERTIS CV, a randomized trial of the sodium-glucose cotransporter-2 inhibitor ertugliflozin","volume":"25","author":"Corbin","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clnu.2024.02.006_bib30","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1038\/oby.2011.42","article-title":"The lipid accumulation product is associated with increased mortality in normal weight postmenopausal women","volume":"19","author":"Wehr","year":"2011","journal-title":"Obesity"},{"key":"10.1016\/j.clnu.2024.02.006_bib31","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/oby.2009.453","article-title":"The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study","volume":"18","author":"Ioachimescu","year":"2010","journal-title":"Obesity"},{"key":"10.1016\/j.clnu.2024.02.006_bib32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12916-014-0154-x","article-title":"Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA","volume":"12","author":"Cheung","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.clnu.2024.02.006_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2337\/dc20-1997","article-title":"Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: the need for systematic screening","volume":"44","author":"Lomonaco","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2024.02.006_bib34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.pcd.2020.02.011","article-title":"Fatty liver index and risk of diabetes incidence: a systematic review and dose-response meta-analysis of cohort studies","volume":"14","author":"Movahedian","year":"2020","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.clnu.2024.02.006_bib35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12933-022-01642-1","article-title":"Fatty liver index as a predictor for incident type 2 diabetes in community-dwelling adults: longitudinal findings over 12 years","volume":"21","author":"Seo","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.clnu.2024.02.006_bib36","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s40200-022-01114-z","article-title":"Association of lipid accumulation product with type 2 diabetes mellitus, hypertension, and mortality: a systematic review and meta-analysis","volume":"21","author":"Khanmohammadi","year":"2022","journal-title":"J\u00a0Diabetes Metab Disord"},{"key":"10.1016\/j.clnu.2024.02.006_bib37","doi-asserted-by":"crossref","first-page":"109208","DOI":"10.1016\/j.diabres.2022.109208","article-title":"Long-term effects of the changes in hepatic steatosis status on the risk of incident type 2 diabetes mellitus: a 15-year community-based prospective cohort study","volume":"184","author":"Chung","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clnu.2024.02.006_bib38","doi-asserted-by":"crossref","first-page":"154893","DOI":"10.1016\/j.metabol.2021.154893","article-title":"The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: a population-based cohort study","volume":"128","author":"Kouvari","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.clnu.2024.02.006_bib39","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clnu.2024.02.006_bib40","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2024.02.006_bib41","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2024.02.006_bib42","doi-asserted-by":"crossref","first-page":"154320","DOI":"10.1016\/j.metabol.2020.154320","article-title":"The role of Omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease","volume":"111S","author":"Perakakis","year":"2020","journal-title":"Metabolism"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424000487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424000487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T14:05:15Z","timestamp":1715263515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561424000487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0261561424000487"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2024.02.006","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-invasive tools for liver steatosis and steatohepatitis predict incidence of diabetes, cardiovascular disease and mortality 20 years later: The ATTICA cohort study (2002\u20132022)","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2024.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}